addS

Wednesday 6 January 2016

Alitair Pharmaceuticals, Inc. - Product Pipeline Review - 2015: Market Research, Overview and Development Trends and Analysis report

Alitair Pharmaceuticals, Inc. - Product Pipeline Review - 2015, provides an overview of the Alitair Pharmaceuticals, Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Alitair Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=502788

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

- The report provides brief overview of Alitair Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Alitair Pharmaceuticals, Inc.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Alitair Pharmaceuticals, Inc.s pipeline products

Reasons to buy

- Evaluate Alitair Pharmaceuticals, Inc.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Alitair Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Alitair Pharmaceuticals, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Alitair Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Alitair Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Alitair Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=502788

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Dermira Inc. - Product Pipeline Review - 2015: New drug targets and therapeutic classes, growth potential, emerging players and dormant and discontinued projects Analysis report

This report provides comprehensive information on the current therapeutic developmental pipeline of Dermira Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=502791

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

- The report provides brief overview of Dermira Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Dermira Inc.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Dermira Inc.s pipeline products

Reasons to buy

- Evaluate Dermira Inc.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Dermira Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Dermira Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Dermira Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Dermira Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Dermira Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=502791

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Applied Immune Technologies Ltd - Product Pipeline Review - 2015: Market Research, Overview and Development Trends and Analysis report

Applied Immune Technologies Ltd - Product Pipeline Review - 2015, provides an overview of the Applied Immune Technologies Ltds pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Applied Immune Technologies Ltds, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=502794

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

- The report provides brief overview of Applied Immune Technologies Ltd including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Applied Immune Technologies Ltds human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Applied Immune Technologies Ltds pipeline products

Reasons to buy

- Evaluate Applied Immune Technologies Ltds strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Applied Immune Technologies Ltd in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Applied Immune Technologies Ltds R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Applied Immune Technologies Ltd and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Applied Immune Technologies Ltd
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Applied Immune Technologies Ltd and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=502794

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Duchenne Muscular Dystrophy - Pipeline Review, H2 2015: Therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

Duchenne Muscular Dystrophy - Pipeline Review, H2 2015, provides an overview of the Duchenne Muscular Dystrophys therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Duchenne Muscular Dystrophy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Duchenne Muscular Dystrophy and special features on late-stage and discontinued projects.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=502800

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

- The report provides a snapshot of the global therapeutic landscape of Duchenne Muscular Dystrophy
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Duchenne Muscular Dystrophy and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Duchenne Muscular Dystrophy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Duchenne Muscular Dystrophy pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Duchenne Muscular Dystrophy
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Duchenne Muscular Dystrophy pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=502800

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Pulmonary Hypertension - Pipeline Review, H2 2015: R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products

Pulmonary Hypertension - Pipeline Review, H2 2015, provides an overview of the Pulmonary Hypertensions therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Pulmonary Hypertension, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Pulmonary Hypertension and special features on late-stage and discontinued projects.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=502797

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

- The report provides a snapshot of the global therapeutic landscape of Pulmonary Hypertension
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Pulmonary Hypertension and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Pulmonary Hypertension products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Pulmonary Hypertension pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Pulmonary Hypertension
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Pulmonary Hypertension pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=502797

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Overview of the Sage Therapeuticss pharmaceutical research and development focus

Global Markets Directs, Sage Therapeutics - Product Pipeline Review - 2015, provides an overview of the Sage Therapeuticss pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Sage Therapeuticss, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

To Browse a Full Report with TOC@ http://www.researchmoz.us/sage-therapeutics-product-pipeline-review-2015-report.html

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=502755

Scope

- The report provides brief overview of Sage Therapeutics including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Sage Therapeuticss human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Sage Therapeuticss pipeline products

Reasons to buy

- Evaluate Sage Therapeuticss strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Sage Therapeutics in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Sage Therapeuticss R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Sage Therapeutics and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sage Therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Sage Therapeutics and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=502755

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Delenex Therapeutics AG - Product Pipeline Review - 2015: Market Research, Overview and Development Trends and Analysis report

Delenex Therapeutics AG - Product Pipeline Review - 2015, provides an overview of the Delenex Therapeutics AGs pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Delenex Therapeutics AGs, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=502752

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

- The report provides brief overview of Delenex Therapeutics AG including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Delenex Therapeutics AGs human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Delenex Therapeutics AGs pipeline products

Reasons to buy

- Evaluate Delenex Therapeutics AGs strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Delenex Therapeutics AG in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Delenex Therapeutics AGs R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Delenex Therapeutics AG and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Delenex Therapeutics AG
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Delenex Therapeutics AG and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=502752

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

China Grand Wuhan General Pharmaceutical Research Institute - Product Pipeline Review - 2015: R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products

Global Markets Directs, China Grand Wuhan General Pharmaceutical Research Institute - Product Pipeline Review - 2015, provides an overview of the China Grand Wuhan General Pharmaceutical Research Institutes pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of China Grand Wuhan General Pharmaceutical Research Institutes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=502749

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

- The report provides brief overview of China Grand Wuhan General Pharmaceutical Research Institute including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of China Grand Wuhan General Pharmaceutical Research Institutes human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the China Grand Wuhan General Pharmaceutical Research Institutes pipeline products

Reasons to buy

- Evaluate China Grand Wuhan General Pharmaceutical Research Institutes strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of China Grand Wuhan General Pharmaceutical Research Institute in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the China Grand Wuhan General Pharmaceutical Research Institutes R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of China Grand Wuhan General Pharmaceutical Research Institute and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of China Grand Wuhan General Pharmaceutical Research Institute
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of China Grand Wuhan General Pharmaceutical Research Institute and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=502749

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

RXi Pharmaceuticals Corporation - Product Pipeline Review - 2015: Therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

Global Markets Directs, RXi Pharmaceuticals Corporation - Product Pipeline Review - 2015, provides an overview of the RXi Pharmaceuticals Corporations pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of RXi Pharmaceuticals Corporations, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=502746

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

- The report provides brief overview of RXi Pharmaceuticals Corporation including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of RXi Pharmaceuticals Corporations human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the RXi Pharmaceuticals Corporations pipeline products

Reasons to buy

- Evaluate RXi Pharmaceuticals Corporations strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of RXi Pharmaceuticals Corporation in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the RXi Pharmaceuticals Corporations R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of RXi Pharmaceuticals Corporation and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of RXi Pharmaceuticals Corporation
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of RXi Pharmaceuticals Corporation and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=502746

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Tuesday 5 January 2016

Overview of the Hanmi Pharmaceuticals, Co. Ltd.s pharmaceutical research and development focus

Hanmi Pharmaceuticals, Co. Ltd. - Product Pipeline Review - 2015, provides an overview of the Hanmi Pharmaceuticals, Co. Ltd.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Hanmi Pharmaceuticals, Co. Ltd.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=502743

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope


- The report provides brief overview of Hanmi Pharmaceuticals, Co. Ltd. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Hanmi Pharmaceuticals, Co. Ltd.s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Hanmi Pharmaceuticals, Co. Ltd.s pipeline products

Reasons to buy


- Evaluate Hanmi Pharmaceuticals, Co. Ltd.s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Hanmi Pharmaceuticals, Co. Ltd. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Hanmi Pharmaceuticals, Co. Ltd.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Hanmi Pharmaceuticals, Co. Ltd. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hanmi Pharmaceuticals, Co. Ltd.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Hanmi Pharmaceuticals, Co. Ltd. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=502743

About ResearchMoz


ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:


Mr. Nachiket

Email:
sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

EndoStim, Inc - Product Pipeline Analysis, 2015 Update

Summary

EndoStim, Inc (EndoStim) is a medical device company that develops and commercializes a neurostimulation system for the treatment of severe gastroesophageal reflux disease. The company concentrates on the treatment of gastroesophageal reflux disease through electrical stimulation. It also conducts clinical research for various drugs. EndoStim has also conducted research on common symptoms and causes of gastroesophageal reflux disease. The company has presence in Europe, Asia, and Latin America. It markets its products in domestic and international healthcare markets through its network of distributors. EndoStim is headquartered in Saint Louis, Missouri, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

To Browse a Full Report with TOC@ http://www.researchmoz.us/endostim-inc-product-pipeline-analysis-2015-update-report.html

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company EndoStim, Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=501975

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=501975

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

CD Diagnostics, Inc. - Product Pipeline Analysis, 2015 Update

Summary

CD Diagnostics, Inc. (CD Diagnostics) is a medical device company that provides integrated diagnostic solutions. The company offers synovascure analytical tools. Its products are used in alpha defenses, CRP, and hemoglobin tests, incubation of anaerobic and aerobic blood culture bottles, measurement of kidney health, determination of cobalt and nickel concentrates, and others. The company provides custom companion diagnostic development programs to complement pharmaceutical drug development and other targeted therapies. It distributes its products through its corporate partnerships in domestic and overseas markets. CD Diagnostics is headquartered in Claymont, Delaware, the US.

To Browse a Full Report with TOC@ http://www.researchmoz.us/cd-diagnostics-inc-product-pipeline-analysis-2015-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company CD Diagnostics, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=501990

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=501990

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Carclo Diagnostic Solutions Ltd - Product Pipeline Analysis, 2015 Update

Summary

Carclo Diagnostic Solutions Ltd (CDS) is a medical equipment company that offers products such as micropoc, micropoc lite, micropoc cat, micropoc pro and capillary agglutination technology. The companys micropoc lite is a qualitative device which could be used for blood group testing and, theoretically, for allergies, among others. Its test result is provided by a simple, non-electronic mechanism such as yes or no result. CDS micropoc cat is a quantitative device based on capillary agglutination technology with a simple electronic display. The companys device could be used for assays such as D-dimer, and blood coagulation, among others. Its micropoc pro is a quantitative device used to detect colour change and it may be used to transfer existing assays from an ELISA format to a POC platform. CDS is headquartered in Ossett, the UK.

To Browse a Full Report with TOC@ http://www.researchmoz.us/carclo-diagnostic-solutions-ltd-product-pipeline-analysis-2015-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Carclo Diagnostic Solutions Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=501984

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=501984

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Courtagen Life Sciences, Inc. - Product Pipeline Analysis, 2015 Update

Summary

Courtagen Life Sciences, Inc. (Courtagen) is a medical device company that provides neurological treatment solutions. The company offers products such as neuro-development panels, lysosomal disorder panels, syndrome panels, comprehensive epilepsy panels, focus epilepsy panels, metabolism test equipments and mitochondrial panels. It also provides drug development services such as target discovery, validation, clinical development, clinical trials, decentralized test development, pre-clinical and clinical trial protocol and companion diagnostic services. The companys products are used in treatment of mitochondrial disorders, epilepsy and seizure disorders, and neuro-developmental disorders. It has its presence in the US and Bermuda. Courtagen is headquartered in Woburn, Massachusetts, the US.

To Browse a Full Report with TOC@ http://www.researchmoz.us/courtagen-life-sciences-inc-product-pipeline-analysis-2015-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Courtagen Life Sciences, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=501972

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=501972

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Precision Medical Devices, Inc. - Product Pipeline Analysis, 2015 Update

Precision Medical Devices, Inc. (PMD) is a medical device company that designs and develops medical devices which are used to treat chronic diseases and disorders. The company's product Politano-Sayet-Sutherland flow control device is designed to treat severe urinary incontinence. It develops products and solutions to treat the chronic conditions such as fecal incontinence, obesity, erectile dysfunction and gastro-esophageal reflux disease. PMD specializes in flow control device technology for treating severe urinary incontinence. The company also undertakes engineering projects which include development of new devices that treat chronic conditions. PMD is headquartered in Fort Lauderdale, Florida, the US.

To Browse a Full Report with TOC@ http://www.researchmoz.us/precision-medical-devices-inc-product-pipeline-analysis-2015-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Precision Medical Devices, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=501981

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=501981

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

BioPolymer GmbH & Co. KG - Product Pipeline Analysis, 2015 Update

BioPolymer GmbH & Co. KG (BioPolymer) is a medical equipment company that researches, develops, and produces hyaluronic acid-based products for orthopedics. The company offers products such as crespine gel and crespine gel plus. It caters its products to physicians, clinics and medical centers. BioPolymers products contain raw materials crosslinked in a way that makes the products stable in human body. The companys products offer optimized injection behavior that is reflected in the thixotropic properties of the hyaluronic acid. It has distributions in Africa, Asia, Australia, Europe, North America, and South America. BioPolymer is headquartered in Dummer, Germany.

To Browse a Full Report with TOC@ http://www.researchmoz.us/biopolymer-gmbh-and-co-kg-product-pipeline-analysis-2015-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=501993

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company BioPolymer GmbH & Co. KG
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=501993

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Wave 80 Biosciences, Inc. - Product Pipeline Analysis, 2015 Update

Wave 80 Biosciences, Inc. (Wave 80) is a medical technology company that develops molecular diagnostic instruments and consumables for the clinical laboratory testing systems markets. It develops molecular diagnostics instruments for chlamydia, respiratory illness, cancers, autoimmune diseases, hepatitis B, hepatitis C, HIV/AIDS and other human health conditions. The companys technology is the EOSCAPE molecular diagnostics system, which facilitates provision of molecular testing in smaller hospitals and clinics. Its lead product, EOSCAPE-HIV, is an in vitro nucleic acid assay, which enables the detection and quantitation of human immunodeficiency virus type 1 (HIV-1) RNA. Wave 80 product pipeline comprises assays for infectious and non-infectious diseases such as EOSCAPE-HBV DNA, EOSCAPE-HIV RNA PLUS, EOSCAPE-TB, EOSCAPE-TB-DST, EOSCAPE-HBV DNA PLUS, EOSCAPE-HCV RNA and EOSCAPE-STD. Wave 80 is headquartered in San Francisco, California, the US.

To Browse a Full Report with TOC@ http://www.researchmoz.us/wave-80-biosciences-inc-product-pipeline-analysis-2015-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=501978

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Wave 80 Biosciences, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=501978

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

ElMinda Ltd. - Product Pipeline Analysis, 2015 Update

ElMinda Ltd. (ElMinda) is a medical technology company that provides brain disorder management solutions. The company offers tools and technologies in the areas of neuropsychological tests, functional magnetic resonance imaging, positron emission tomography, electroencephalography and magnetic encephalography. Its neuropsychological tests comprise questionnaires, pencil and paper test, computerized NP tests and continuous performance tests and behavioral or performance tests that provide an assessment of cognitive functioning. The company offers research and development programs in the areas of recovery management, pharmacologic treatment optimization, ADHD diagnosis and treatment optimization, pain management, early detection of neurodegenerative diseases, and mood disorders. It has its presence in Israel and the US. ElMinda is headquartered in Herzliya, Israel.

To Browse a Full Report with TOC@ http://www.researchmoz.us/elminda-ltd-product-pipeline-analysis-2015-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company ElMinda Ltd.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=501987

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=501987

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Bio-Alternative Medical Devices Ltd - Product Pipeline Analysis, 2015 Update

Bio-Alternative Medical Devices Ltd (Bio AMD) is a medical device company that designs, develops, and markets point of care medical diagnostic products. The company offers products such as blood coagulation monitor, digital strip reader, and magnetic immunoassay detection system. Its blood coagulation monitor provides day to day control of anti-coagulant intake to patientdigital strip reader provides reading of numerous lateral flow strips to detect differing conditions including pregnancy, fertility and ovulationand magnetic immunoassay detection system offers enhanced sensitivity based on magnetic nano-particle manipulation and detection, interpreting results on a quantitative basis. Bio AMD is headquartered in Daresbury, the UK.

To Browse a Full Report with TOC@ http://www.researchmoz.us/bio-alternative-medical-devices-ltd-product-pipeline-analysis-2015-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Bio-Alternative Medical Devices Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=501969

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=501969

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074

Genetic Analysis AS - Product Pipeline Analysis, 2015 Update

Genetic Analysis AS (Genetic Analysis) is a molecular diagnostic company that offers technology services. The company provides molecular diagnostics of diseases related to gut imbalances. It has developed DNA-based GA-map technology. Genetic Analysiss products include GA-map MFA, GA-map CORE, GA-map IBD, GA-map IBS dysbiosis test, GA-map obesity, and GA-map diabetes II. Genetic Analysis technology utilizes common and variable DNA sequences within specified 16S rRNA gene of the bacteria to identify the different bacteria. Its GA-map ProbeTool software program uses search mechanisms to find combinations of DNA probes that can be used in the test. Genetic Analysis is headquartered in Oslo, Norway.

To Browse a Full Report with TOC@ http://www.researchmoz.us/genetic-analysis-as-product-pipeline-analysis-2015-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Genetic Analysis AS
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=501966

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

To Enquire Regarding This Report@ http://www.researchmoz.us/enquiry.php?type=E&repid=501966

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket

Email: sales@researchmoz.us
Blog: http://dynamicmarketresearch.blogspot.com/
Tel: 866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-621-2074